| |
||||
|
MassMEDIC
to Brief Massachusetts Congressional Delegation on MDUFMA Reauthorization
MassMEDIC will deliver a policy statement, developed by the FDA Working Group and Board of Directors, on the reauthorization of the user fee program and FDA performance goals to Massachusetts staff and Members. Details on the briefing will be posted on MassMEDIC’s website (Meetings
and Events) shortly.
|